13 min listen
US Food and Drug Administration Perspectives on Clinical Mass Spectrometry
US Food and Drug Administration Perspectives on Clinical Mass Spectrometry
ratings:
Length:
9 minutes
Released:
Jan 27, 2016
Format:
Podcast episode
Description
Mass spectrometry–based in vitro diagnostic devices that measure proteins and peptides are underutilized in clinical practice, and none has been cleared or approved by the Food and Drug Administration (FDA) for marketing or for use in clinical trials. One way to increase their utilization is through enhanced interactions between the FDA and the clinical mass spectrometry community to improve the validation and regulatory review of these devices.
Released:
Jan 27, 2016
Format:
Podcast episode
Titles in the series (100)
Determination of Total Homocysteine, Methylmalonic Acid, and 2-Methylcitric Acid in Dried Blood Spots by Tandem Mass Spectrometry by Clinical Chemistry Podcast